Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04572_nanopub.RA4S-CrdZTdrlesoQ6vrCN1aR9KtmV16qHMijPZvL74gI#assertion>. }
Showing items 1 to 20 of
20
with 100 items per page.
- drugbank:DB04572 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04572 label "Thiotepa [drugbank:DB04572]" assertion.
- drugbank:DB04572 seeAlso DB04572 assertion.
- drugbank:DB04572 seeAlso thiotepa.html assertion.
- drugbank:DB04572 seeAlso thiotepa-drug.htm assertion.
- drugbank:DB04572 identifier "drugbank:DB04572" assertion.
- drugbank:DB04572 description "N,N'N'-triethylenethiophosphoramide (ThioTEPA) is a cancer chemotherapeutic member of the alkylating agent group, now in use for over 50 years. It is a stable derivative of N,N',N''- triethylenephosphoramide (TEPA). It is mostly used to treat breast cancer, ovarian cancer and bladder cancer. It is also used as conditioning for Bone marrow transplantation. Its main toxicity is myelosuppression." assertion.
- drugbank:DB04572 title "Thiotepa" assertion.
- drugbank:DB04572 bio2rdf_vocabulary:identifier "DB04572" assertion.
- drugbank:DB04572 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04572 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04572" assertion.
- drugbank:DB04572 bio2rdf_vocabulary:x-identifiers.org DB04572 assertion.
- drugbank:DB04572 drugbank_vocabulary:drugbank-id "DB04572" assertion.
- drugbank:DB04572 drugbank_vocabulary:x-cas cas:52-24-4 assertion.
- drugbank:DB04572 drugbank_vocabulary:x-atc atc:L01AC01 assertion.
- drugbank:DB04572 drugbank_vocabulary:x-kegg kegg:C07641 assertion.
- drugbank:DB04572 drugbank_vocabulary:x-kegg kegg:D00583 assertion.
- drugbank:DB04572 drugbank_vocabulary:x-pharmgkb pharmgkb:PA451668 assertion.
- drugbank:DB04572 drugbank_vocabulary:x-wikipedia wikipedia:Thiotepa assertion.
- drugbank:DB04572 drugbank_vocabulary:x-ndc ndc:55390-030-10 assertion.